BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1800)

  • 1. Effect of propranolol on antinociceptive and withdrawal characteristics of morphine.
    Chipkin RE; Dewey WL; Harris LS; Lowenthal W
    Pharmacol Biochem Behav; 1975; 3(5):843-7. PubMed ID: 1800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of propranolol on antinociceptive, tolerance- and dependence-producing properties of morphine in rodents and monkeys.
    Cowan A; Macfarlane IR
    Eur J Pharmacol; 1975 Nov; 34(1):87-94. PubMed ID: 11999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased antagonist potency of naloxone caused by morphine pretreatment in mice.
    Wong CL; Bentley CA
    Eur J Pharmacol; 1978 Feb; 47(4):415-22. PubMed ID: 564774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions.
    Fielding S; Wilker J; Hynes M; Szewczak M; Novick WJ; Lal H
    J Pharmacol Exp Ther; 1978 Dec; 207(3):899-905. PubMed ID: 569695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN
    Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary studies on increased naloxone potency and its relationship to morphine tolerance and dependence in mice.
    Wong CL; Wai MK; Roberts MB
    Clin Exp Pharmacol Physiol; 1980; 7(3):305-10. PubMed ID: 7190475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
    Yano I; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome.
    Dogrul A; Zagli U; Tulunay FC
    Life Sci; 2002 Jun; 71(6):725-34. PubMed ID: 12072160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pargyline on morphine tolerance and physical dependence development in mice.
    Iwamoto ET; Ho IK; Way EL
    Eur J Pharmacol; 1976 Aug; 38(2):261-8. PubMed ID: 986307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):689-96. PubMed ID: 12548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: investigations by the ED50 value and CNS content of naloxone.
    Miyamoto Y; Takemori AE
    Drug Alcohol Depend; 1993 Apr; 32(2):163-7. PubMed ID: 8389690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociception and physical dependence produced by [D-Arg2] dermorphin tetrapeptide analogues and morphine in rats.
    Chaki K; Kawamura S; Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Susuki K
    Br J Pharmacol; 1988 Sep; 95(1):15-22. PubMed ID: 2905901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic administration of caffeine on morphine-induced analgesia, tolerance and dependence in mice.
    Ahlijanian MK; Takemori AE
    Eur J Pharmacol; 1986 Jan; 120(1):25-32. PubMed ID: 3005000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.